References
- Kriett J M, Kaye M P. The Registry of the International Society for Heart Transplantation: seventh official report, 1990. J Heart Transplant 1990; 9: 323–330
- Grossi P, De Maria R, Caroli A, Zaina M S, Minoli L. The Italian Study Group on Infections in Heart Transplantation. Infections in heart transplant recipients: the experience of the Italian heart transplant program. J Heart Lung Transplant 1992; 11: 847–866
- Renlund D, O'Connell J B, Bristow M R. Strategies of immunosuppression in cardiac transplantation. Semin Thorac Cardiovasc Surg 1990; 2: 181–188
- Laske A, Gallino A, Schneider J, Baur E P, Carrel T, Pasic M, von Segesser L K, Turina M I. Prophylactic therapy in heart transplantation: monoclonal versus polyclonal antibody therapy. J Heart Lung Transplant 1992; 11: 557–563
- Costanzo-Nordin M R, Swinnen L J, Fisher S G, O'Sullivan E J, Piforre R, Hereaux A I, Mullen G M, Johnson M R. Cytomegalovirus infections in heart transplant recipients: relationship to immunosuppression. J Heart Lung Transplant 1992; 11: 837–846
- Andersson R, Sandberg T, Berglin E, Jeansson S. Cytomegalovirus infections and toxoplasmosis in heart transplant recipients in Sweden. Scand J Infect Dis 1992; 24: 411–417
- Gorensek M J, Stewart R W, Keys T F, McHenry M C, Goormestic M. A multivariate analysis of the risk of cytomegalovirus infection in heart transplant recipients. J Infect Dis 1988; 157: 515–522
- Smyth R L, Scott J P, Borysiewicz, Sharploes L D, Stewart S, Wreghitt T G, Gray J J, Higenbottom T W, Wallwork J. Cytomegalovirus infection in heart-lung transplant recipients: risk factors, clinical associations and response to treatment. J Infect Dis 1991; 164: 1045–1050
- Augustine S M, Yeo C J, Buchman T G, Achuff S C, Baumgartner W A. Gastrointestinal complications in heart and in heart-lung transplant patients. Transplantation 1991; 10: 547–555
- Loebe M, Schuler S, Zais O, Warnecke H, Fleck E, Hetzer R. Role of cytomegalovirus infection in the development of coronary artery disease in the transplanted heart. J Heart Transplant 1990; 9: 707–711
- Sharples L D, Caine N, Mullins P, Scott J P, Solis E, English T AH, Large S R, Schofield P M, Wallwork J. Risk factor analysis for the major hazards following heart transplantation-rejection, infection, and coronary occlusive disease. Transplantation 1991; 52: 244–252
- Goodrich J M, Mori M, Gleaves C A, DuMond C, Cays M, Ebeling D F, Buhles W C, DeArmond B, Meyers J D. Early treatment with ganciclovir to prevent cytomegalovirus disease after allogenic bone marrow transplantation. N Engl J Med 1991; 325: 1601–1607
- Dunn D L, Mayoral J L, Gillingham K J, Loeffler C M, Brayman K L, Kramer M A, Erice A, Balfour H H, Fletcher C V, Bolman R M, Matas A J, Payne W D, Sutherland D ER, Najarian J S. Treatment of invasive cytomegalovirus disease in solid organ transplant patients with ganciclovir. Transplantation 1991; 51: 98–106
- Merigan T H, Renlund D G, Keay S, Bristow M R, Starnes V, O'Connell J B, Resta S, Dunn D, Gamberg P, Ratkovec R M, Richenbacher W E, Millar R C, DuMond C, DeAmond B, Sullivan V, Cheney T, Buhles W, Stinson E B. A controlled trial of ganciclovir to prevent cytomegalovirus disease after heart transplantation. N Engl J Med 1992; 326: 1182–1186
- Billingham M E, Cary N R, Hammond M E, Kemnitz J, Marboe C, Callister H A, Snovar D C, Winters G L, Zerbe A. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart rejection study group. J Heart Transplant 1990; 9: 587–593
- Meyers J D, Reed E C, Shepp D H, Thornquist M, Dandliker P S, Vicary C A, Flournoy N, Kirk L E, Kersey J H, Thomas E D. Acyclovir for prevention of cytomegalovirus infection and disease after allogenic marrow transplantation. N Engl J Med 1988; 318: 70–75
- Balfour H H, Chace B A, Stapleton J T, Simmons R L, Fryd D S. A randomized, placebo-controlled trial of oral acyclovir for the prevention of cytomegalovirus disease in recipients of renal allografts. N Engl J Med 1989; 320: 1381–1387
- Havel M, Teufelsbauer H, Laczkovics A, Kurz R, Wolner E. Cytomegalovirus hyperimmunoglobulin prophylaxis in the prevention of cytomegalovirus infection in immunosuppressed heart transplant patients. Transplant Proc 1990; 22: 1805–1806
- Rubin R H. Impact of cytomegalovirus infection on organ transplant recipients. Rev Infect Dis Suppl 1990; 7: S754–S762
- Boyce N W, Hayes K, Gee D, Holdsworth S R, Thomson N M, Scott D, Atkins R C. Cytomegalovirus infection complicating renal transplantation and its relationship to acute transplant glomerulopathy. Transplantation 1988; 45: 706–709